TCI GENE Inc. (TPEX:6879)
36.30
-0.20 (-0.55%)
Jan 22, 2026, 11:16 AM CST
TCI GENE Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 270.62 | 98.43 | 696.05 | 932.74 | 326.19 | 177.57 |
Short-Term Investments | 447.17 | 576.1 | 201.1 | 2.5 | 3.5 | - |
Trading Asset Securities | 166.16 | 159.9 | - | - | - | - |
Cash & Short-Term Investments | 883.95 | 834.43 | 897.15 | 935.24 | 329.69 | 177.57 |
Cash Growth | -10.56% | -6.99% | -4.07% | 183.68% | 85.67% | - |
Accounts Receivable | 74.36 | 95.66 | 102.59 | 73.08 | 116.9 | 44.75 |
Other Receivables | 0.3 | 9.66 | 0.86 | 0.99 | 1.08 | 2.91 |
Receivables | 74.66 | 105.33 | 103.45 | 74.06 | 117.98 | 47.66 |
Inventory | 30.51 | 46.48 | 57.86 | 57.26 | 32.64 | 31.25 |
Prepaid Expenses | 11.71 | 4.79 | 7.72 | 6.77 | 4.71 | 1.98 |
Other Current Assets | 4.49 | 3.26 | 2.55 | 2.72 | 1.26 | 1.04 |
Total Current Assets | 1,005 | 994.28 | 1,069 | 1,076 | 486.28 | 259.5 |
Property, Plant & Equipment | 17.1 | 10.88 | 21.91 | 25.49 | 41.71 | 21.63 |
Long-Term Investments | 76.71 | 70.72 | 60.65 | 49.26 | 18.69 | 2.28 |
Goodwill | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 |
Other Intangible Assets | 2.51 | 3.08 | 4.21 | 4.88 | 4.47 | 7.08 |
Other Long-Term Assets | 3.79 | 18.68 | 8.99 | 6.18 | 7.71 | 23.37 |
Total Assets | 1,107 | 1,099 | 1,166 | 1,163 | 560.31 | 315.33 |
Accounts Payable | 53.13 | 40.56 | 75.92 | 60.47 | 72.74 | 53.58 |
Accrued Expenses | 26.51 | 23.78 | 32.61 | 32.61 | 29.48 | 14.82 |
Current Portion of Leases | 9.27 | - | 6.21 | 1.88 | 6.83 | - |
Current Income Taxes Payable | 6.08 | 12.3 | 10.67 | 21.9 | 23.89 | 10.13 |
Current Unearned Revenue | 5.4 | 4.12 | 5.63 | 5.96 | 11.46 | 12.42 |
Other Current Liabilities | 74.83 | 20.54 | 24.51 | 20.35 | 24.98 | 8.3 |
Total Current Liabilities | 175.22 | 101.29 | 155.55 | 143.17 | 169.38 | 99.25 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.44 |
Other Long-Term Liabilities | - | - | - | - | 0.06 | 0.06 |
Total Liabilities | 178.51 | 101.29 | 155.55 | 143.17 | 169.44 | 99.75 |
Common Stock | 264.59 | 264.59 | 264.59 | 264.59 | 214.59 | 155.93 |
Additional Paid-In Capital | 602.37 | 607.77 | 604.76 | 595.78 | 47.68 | 1.2 |
Retained Earnings | 51.65 | 113.46 | 83.61 | 124.85 | 106.35 | 51.85 |
Comprehensive Income & Other | -10.74 | -11.08 | 33.56 | 19.91 | 11.58 | -1.07 |
Total Common Equity | 907.87 | 974.73 | 986.51 | 1,005 | 380.2 | 207.91 |
Minority Interest | 20.52 | 23.08 | 23.88 | 15.04 | 10.67 | 7.68 |
Shareholders' Equity | 928.38 | 997.81 | 1,010 | 1,020 | 390.88 | 215.59 |
Total Liabilities & Equity | 1,107 | 1,099 | 1,166 | 1,163 | 560.31 | 315.33 |
Total Debt | 12.57 | - | 6.21 | 1.88 | 6.83 | - |
Net Cash (Debt) | 871.39 | 834.43 | 890.94 | 933.36 | 322.86 | 177.57 |
Net Cash Growth | -11.55% | -6.34% | -4.54% | 189.09% | 81.83% | - |
Net Cash Per Share | 32.83 | 31.45 | 33.64 | 37.96 | 16.31 | 9.49 |
Filing Date Shares Outstanding | 26.46 | 26.46 | 26.46 | 26.46 | 21.46 | 18.46 |
Total Common Shares Outstanding | 26.46 | 26.46 | 26.46 | 26.46 | 21.46 | 18.46 |
Working Capital | 830.1 | 892.99 | 913.17 | 932.88 | 316.9 | 160.25 |
Book Value Per Share | 34.31 | 36.84 | 37.28 | 37.99 | 17.72 | 11.26 |
Tangible Book Value | 903.89 | 970.19 | 980.84 | 998.78 | 374.27 | 199.36 |
Tangible Book Value Per Share | 34.16 | 36.67 | 37.07 | 37.75 | 17.44 | 10.80 |
Machinery | 53.54 | 53.4 | 74.82 | 74.08 | 68.03 | 26.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.